| Hirayama Y, Terui T, Koike K, et al.
Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia. [Journal Article]
Rinsho Ketsueki 2009 Aug; 50(8):663-5.
Abstract | Full Citation | Find Related Articles | | Sumi M, Ichikawa N, Nasu K, et al.
Gemtuzumab ozogamicin-induced long-term remission in a woman with acute myelomonocytic leukemia and bone marrow relapse following allogeneic transplantation. [JOURNAL ARTICLE]
Int J Hematol 2009 Nov 11.
Abstract | Full Citation | | Nagai T
[Combination chemotherapy for acute myeloid leukemia] [English Abstract, Journal Article]
Nippon Rinsho 2009 Oct; 67(10):1921-5.
Abstract | Full Citation | Find Related Articles | | Chevallier P, Prebet T, Pigneux A, et al.
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin. [JOURNAL ARTICLE]
Leukemia 2009 Oct 22.
Full Citation | Find Related Articles | | Papayannidis C, Derenzini E, Iacobucci I, et al.
Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia. [JOURNAL ARTICLE]
Am J Hematol 2009 Sep 16.
Full Citation | | Martin MG, Augustin KM, Uy GL, et al.
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF. [JOURNAL ARTICLE]
Am J Hematol 2009 Sep 11.
Abstract | Full Citation | | Litzow MR, Othus M, Cripe LD, et al.
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group. [JOURNAL ARTICLE]
Br J Haematol 2009 Oct 5.
Abstract | Full Citation | | Morris JC, Waldmann TA
Antibody-based therapy of leukaemia. [Journal Article, Research Support, N.I.H., Intramural]
Expert Rev Mol Med 2009.:e29.
Abstract | Full Citation | Find Related Articles | | Jawad M, Seedhouse C, Mony U, et al.
Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia. [JOURNAL ARTICLE]
Leukemia 2009 Sep 24.
Abstract | Full Citation | | Fernandez HF, Sun Z, Yao X, et al.
Anthracycline dose intensification in acute myeloid leukemia. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
N Engl J Med 2009 Sep 24; 361(13):1249-59.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
